Xiangyang Miao

1.4k citations
48 papers · 1000 indexed · h-index 19
Topics
Cancer-related molecular mechanisms research (29 papers)MicroRNA in disease regulation (19 papers)Circular RNAs in diseases (15 papers)
Partner nations
ChinaPakistan

In The Last Decade

Xiangyang Miao

44 papers receiving 995 citations

Peers

Xiangyang Miao
Comparison fields: 5 of 72
  • Cancer Research 624
  • Molecular Biology 587
  • Genetics 467
  • Agronomy and Crop Science 131
  • Animal Science and Zoology 84
Replace Youji Ma with:
Youji Ma China
Zehu Yuan China
Tatsuo Fujita Japan
Kazunori Mizoshita Japan
Hongjia Ouyang China
Kacper Żukowski Poland
Satoshi Mikawa Japan
Juliette Riquet France
Catherine Collette Sweden
Chugang Mei China
Xiangyang Miao relative to Youji Ma China Youji Ma's profile →
Citations per field
00.5×6.1×
Youji Ma · 1×
Citations per year

Countries citing papers authored by Xiangyang Miao

Since Specialization
Citations

This map shows the geographic impact of Xiangyang Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyang Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyang Miao more than expected).

Fields of papers citing papers by Xiangyang Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyang Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyang Miao. The network helps show where Xiangyang Miao may publish in the future.

Co-authorship network of co-authors of Xiangyang Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyang Miao. A scholar is included among the top collaborators of Xiangyang Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyang Miao. Xiangyang Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 4
5 16
6 2
7 18
8 11
9 19
10 9
11 51
12 46
13 34
14 43
15 64
16 40
17 28
18 3
19 2
20 2

About Xiangyang Miao

Xiangyang Miao is a scholar working on Cancer Research, Genetics and Molecular Biology, having authored 48 papers that have together received 1000 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (29 papers), MicroRNA in disease regulation (19 papers) and Circular RNAs in diseases (15 papers). The work is most often cited by research in Cancer Research (624 citations), Genetics (467 citations) and Agronomy and Crop Science (131 citations). Xiangyang Miao has collaborated with scholars based in China and Pakistan. Frequent co-authors include Qingmiao Luo, Xiaoyu Qin, Huijing Zhao, Wanlong Huang, Juntao Guo, Lingli Xie, Xiuxiu Zhang, Li Ai, Xiuxiu Zhang and Xiaoyu Qin. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Cellular and Molecular Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026